The authors have demonstrated that the silencing of either CARD10 or MALT1 in EGFR-overexpressing lung cancer cells correlates with reduced NF-κB activity, cancer cell proliferation, migration, survival, and tumor burden in vivo. The gene discussed is EGFR; the disease is lung cancer.